Tevogen Bio Holdings (NASDAQ: TVGN) shares are wobbling on Friday as the company is advancing its generics strategy through a signed letter of intent to evaluate a potential acquisition of Apozeal ...
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve chronic disease outcomes for ...
USANewsGroup.com News Commentary -- The global cell therapy market is projected to surpass $8.2 billion in 2026, driven by a wave of clinical breakthroughs and manufacturing milestones reshaping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results